NCT03025841View on ClinicalTrials.gov

Population Pharmacokinetic (PK) Study of Zinforo (Ceftaroline) in Critical Care Patients With Early-onset Pneumonia and Normal or Augmented Renal Clearance

PHASE1CompletedINTERVENTIONAL
Enrollment

18

Participants

Timeline

Start Date

December 31, 2016

Primary Completion Date

December 31, 2017

Study Completion Date

June 30, 2018

Conditions
Pneumonia
Interventions
DRUG

Ceftaroline

Trial Locations (1)

Unknown

CHU poitiers, Poitiers

All Listed Sponsors
lead

Poitiers University Hospital

OTHER

NCT03025841 - Population Pharmacokinetic (PK) Study of Zinforo (Ceftaroline) in Critical Care Patients With Early-onset Pneumonia and Normal or Augmented Renal Clearance | Biotech Hunter | Biotech Hunter